HeartBeam BEAT 深 滬
已收盤 07-02 16:00:00 美东时间
0.72
-0.009
-1.28%
華盛通- 最 高0.7643
- 今 開0.7518
- 成交量 28.09万股
- 最 低 0.70
- 昨 收 0.7293
- 總市值 3996.49万
- 52周最高 4.00
- 市盈率 靜 --
- 換手率 0.51%
- 52周最低 0.54
- 委 比 3.14%
- 總股本 5550.68万
- 歷史最高 71.96
- 量 比 0.44
- 振 幅 8.82%
- 歷史最低 0.54
- 每 手 1
- 風險率 0.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HeartBeam Receives Nasdaq Notice on Minimum Bid Price
HeartBeam ( ($BEAT) ) has issued an update. On June 30, 2026, HeartBeam receive...
07-03 04:54
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
Austin, Texas, United States, June 25th, 2026, FinanceWire HeartBeam (NASDAQ:BE...
06-26 02:30
HeartBeam restructures to license 3D ECG technology
The latest update is out from HeartBeam ( ($BEAT) ). On June 18, 2026, HeartBea...
06-25 05:48
HeartBeam Announces Reorganization To Prioritize Global Market Reach And Capital Efficiency While Accelerating Execution; To License Its 3D ECG Signal Technology To Established Partners
Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device sales Advancing toward heart attack detection as a key expansion of the platform Tailoring its technology to fit each market, while operating with a leaner, more focused structure Company t...
06-25 04:09
HeartBeam研究登权威期刊 居家识别心梗风险获新证
HeartBeam周二宣布，一项经同行评审的研究发表在《美国心脏病学会杂志》子刊《JACC： Advances》上，证明了其心脏监测系统在居家环境下准确识别...
06-02 21:56
HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients
Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack riskStudy advances the scientific foundation
06-02 19:20
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5
Benchmark analyst Bill Sutherland maintains HeartBeam (NASDAQ:BEAT) with a Speculative Buy and lowers the price target from $8 to $5.
05-15 20:37
HeartBeam (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results
Austin, Texas, United States, May 14th, 2026, FinanceWire HeartBeam (NASDAQ:BEA...
05-15 02:30
电话会总结 ｜ HeartBeam(BEAT)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据HeartBeam业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **Q1 2026财务表现：** - **净亏损**：470万美元 - **经营活动现金净流出**：360万美元 - **现金余额**：截至2026年3月31日，现金余额略超200万美元 - **融资情况**：4月完成1150万美元公开股权融资，调整后现金余额约1240万美元 ## 2. 财务指标变化 **同比改善：** - **经营现金流出同比下降19%**：Q1 2026经营活动现金净流出360万美元，较去年同期减少19% - **成本控制效果显著**：在实现商业化
05-14 12:27
